Here are the latest quarterly results of GLENMARK LIFE SCIENCES. For more details, see the GLENMARK LIFE SCIENCES financial fact sheet and GLENMARK LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 5,141 | 4,899 | 5,093 | 5,407 | 6,213 | 5,785 | 5,954 | 5,728 | |
Other income | Rs m | 51 | 95 | 100 | 66 | 28 | 19 | 54 | 17 | |
Turnover | Rs m | 5,192 | 4,994 | 5,193 | 5,473 | 6,242 | 5,803 | 6,007 | 5,745 | |
Expenses | Rs m | 3,718 | 3,431 | 3,657 | 3,953 | 4,149 | 3,853 | 4,283 | 4,002 | |
Gross profit | Rs m | 1,422 | 1,468 | 1,436 | 1,455 | 2,064 | 1,932 | 1,671 | 1,726 | |
Depreciation | Rs m | 96 | 99 | 99 | 108 | 115 | 126 | 131 | 132 | |
Interest | Rs m | 1 | 1 | 1 | 2 | 1 | 4 | 4 | 4 | |
Profit before tax | Rs m | 1,376 | 1,462 | 1,436 | 1,411 | 1,976 | 1,820 | 1,589 | 1,607 | |
Tax | Rs m | 387 | 375 | 367 | 361 | 513 | 466 | 402 | 419 | |
Profit after tax | Rs m | 989 | 1,087 | 1,069 | 1,050 | 1,464 | 1,355 | 1,187 | 1,188 | |
Gross profit margin | % | 27.7 | 30.0 | 28.2 | 26.9 | 33.2 | 33.4 | 28.1 | 30.1 | |
Effective tax rate | % | 28.1 | 25.7 | 25.6 | 25.6 | 25.9 | 25.6 | 25.3 | 26.1 | |
Net profit margin | % | 19.2 | 22.2 | 21.0 | 19.4 | 23.6 | 23.4 | 19.9 | 20.7 | |
Diluted EPS | Rs | 8.1 | 8.9 | 8.7 | 8.6 | 11.9 | 11.1 | 9.7 | 9.7 | |
Diluted EPS (TTM) | Rs | 34.2 | 34.8 | 34.1 | 34.2 | 38.1 | 40.3 | 41.3 | 42.4 | |
Subscriber Feature |
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.